Pharmaceuticals

For Global Markets

HIGH VALUE MOLECULES

INVESTING IN LEADING THERAPEUTIC INNOVATION

Our platform for cutting-edge innovation invests in biologics, biosimilars, rare disease, orphan drugs and other high value molecules.  LSA will fully fund the upstream, downstream, clinical trials and commercialization of small and large molecules.  We look for credible partners  who have have an established track record for commercializing and distributing our vital IP assets. 

Contact us to learn more about our HIGH VALUE MOLECULE INVESTMENT platform.